Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lorenzo Trippa, Ph.D.

Concepts (272)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Research Design29202461743.490 Why?
Bayes Theorem21202423262.900 Why?
Glioblastoma17202334812.560 Why?
Clinical Trials as Topic18202479951.630 Why?
Information Dissemination5202411251.500 Why?
Clinical Trials, Phase I as Topic220243261.470 Why?
Randomized Controlled Trials as Topic182024101991.310 Why?
Clinical Trials, Phase II as Topic420226291.100 Why?
Probability5202324750.900 Why?
Brain Neoplasms13202390260.890 Why?
Medical Futility220221360.860 Why?
Data Interpretation, Statistical6201826890.860 Why?
Maximum Tolerated Dose220248830.830 Why?
Models, Statistical8202450730.800 Why?
Random Allocation4202323920.740 Why?
Controlled Clinical Trials as Topic120211860.720 Why?
Biometry220145610.670 Why?
Drugs, Investigational120212120.630 Why?
Computer Simulation13202362330.630 Why?
Medical Oncology4202323170.600 Why?
Informed Consent1202410070.590 Why?
Carnitine120182520.570 Why?
Kaplan-Meier Estimate7202164740.550 Why?
Benchmarking1202310450.550 Why?
Antineoplastic Combined Chemotherapy Protocols162024117360.520 Why?
Inheritance Patterns120183410.520 Why?
Antineoplastic Agents52024136350.510 Why?
Algorithms122024140180.510 Why?
Tuberculosis, Multidrug-Resistant320219340.490 Why?
Antitubercular Agents4202113740.480 Why?
Multiple Myeloma9202351460.470 Why?
Immunotherapy4202246420.460 Why?
Neoplasms82024221310.450 Why?
Survival Analysis62021100730.440 Why?
Neurology120217800.440 Why?
Breast Neoplasms152021209880.430 Why?
Shock, Septic120187690.400 Why?
Proportional Hazards Models62021124470.390 Why?
Humans9120247606170.380 Why?
Waldenstrom Macroglobulinemia4202210730.370 Why?
Electronic Health Records3202348030.360 Why?
Pedigree1201845390.350 Why?
Monoclonal Gammopathy of Undetermined Significance220231790.350 Why?
Computational Biology3202035090.330 Why?
Head and Neck Neoplasms2202028940.320 Why?
Receptor, erbB-27202125530.300 Why?
Ovarian Neoplasms3202148490.280 Why?
Endpoint Determination520175900.280 Why?
Alleles1201868610.280 Why?
Disease-Free Survival7202168070.270 Why?
Paclitaxel4202117300.270 Why?
Decision Making4202339180.250 Why?
Sepsis1201825850.240 Why?
Receptors, CXCR4220197270.230 Why?
Organophosphorus Compounds120242060.210 Why?
Software2201444310.210 Why?
Prospective Studies82022543600.200 Why?
Clinical Trials, Phase III as Topic220198570.200 Why?
Neurofibromatosis 2120243830.180 Why?
Gene Expression Profiling3202094170.180 Why?
Filgrastim120201320.170 Why?
Camptothecin120235910.170 Why?
Hematopoiesis3202020490.170 Why?
Ketones120201830.170 Why?
Paraproteinemias120222480.160 Why?
Furans120202020.160 Why?
DNA Mismatch Repair120224280.160 Why?
Oxazoles220201990.160 Why?
Uncertainty120247520.160 Why?
Treatment Outcome132021645680.160 Why?
Inappropriate Prescribing120212020.150 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis120223800.150 Why?
Neoadjuvant Therapy4202328270.140 Why?
Sample Size220178380.140 Why?
Anilides120194110.130 Why?
Respiratory Tract Diseases120227500.130 Why?
Neoplasm Recurrence, Local4202392770.130 Why?
Antineoplastic Agents, Alkylating120206170.130 Why?
Factor Analysis, Statistical120199970.130 Why?
Models, Genetic2201834310.130 Why?
Immunoconjugates120239510.130 Why?
Estrogen Receptor alpha120205830.130 Why?
Female3320243921480.130 Why?
Nitroimidazoles120161170.130 Why?
Hematopoietic Stem Cell Transplantation4202256720.130 Why?
Patient Care120216210.120 Why?
Voltage-Sensitive Dye Imaging12014290.120 Why?
Neoplasm, Residual1202010080.120 Why?
Numerical Analysis, Computer-Assisted120141190.120 Why?
Polyethylene Glycols1202011820.120 Why?
Cyclophosphamide1202022180.110 Why?
Data Collection1202333150.110 Why?
Doxorubicin1202022240.110 Why?
BRCA2 Protein120187970.110 Why?
Pharmaceutical Preparations1202110860.110 Why?
Mutation62020300160.100 Why?
Salvage Therapy1201912630.100 Why?
Carcinoma, Ductal, Breast1202010840.100 Why?
Embryo, Mammalian2201616700.100 Why?
Likelihood Functions120159910.100 Why?
Rectal Neoplasms1202111560.100 Why?
Pyrimidines1202430270.100 Why?
Genes, Neoplasm120143700.100 Why?
BRCA1 Protein1201811490.100 Why?
Reproducibility of Results52019200740.090 Why?
Molecular Sequence Annotation120145200.090 Why?
Models, Biological2202094610.090 Why?
High-Throughput Screening Assays120179330.090 Why?
Survival Rate42020127190.090 Why?
Pyridines2202028740.090 Why?
Transplantation, Autologous3202221120.090 Why?
Antibodies, Viral1202131500.090 Why?
Markov Chains120149650.090 Why?
Particulate Matter1202226020.090 Why?
Immunoglobulin G1202145330.080 Why?
Prognosis72020296000.080 Why?
Epidemiologic Methods1201413350.080 Why?
Risk4202296040.080 Why?
Drug Discovery1201710510.080 Why?
Patient Participation1201814430.080 Why?
Oligonucleotide Array Sequence Analysis2201437770.080 Why?
Decision Support Techniques1201919980.080 Why?
Patient Selection1202142370.080 Why?
Life Expectancy1201512390.080 Why?
Point Mutation1201415950.080 Why?
Monte Carlo Method1201412570.080 Why?
Disease Progression52024134950.070 Why?
Receptors, Estrogen3202022080.070 Why?
High-Throughput Nucleotide Sequencing1202036340.070 Why?
Aged1720221690420.070 Why?
Papillomavirus Infections1201916110.070 Why?
Neoplasm Proteins1201936070.070 Why?
Asymptomatic Diseases220215870.070 Why?
Cell Lineage1201625540.070 Why?
Male1720243603580.070 Why?
Drug Administration Schedule3202048450.070 Why?
Genomics2202058220.070 Why?
Environmental Exposure1202244830.070 Why?
Middle Aged1720242205840.070 Why?
Genotype22018129780.070 Why?
DNA Copy Number Variations1201520200.070 Why?
Databases, Factual1202179600.060 Why?
Immunoglobulin M2202215260.060 Why?
Receptors, Progesterone2202011290.060 Why?
Tuberculosis1201820150.060 Why?
Cross-Over Studies2202220790.060 Why?
Single-Cell Analysis1201624470.060 Why?
Recurrence2201984260.060 Why?
Palliative Care1202035920.060 Why?
Drug Resistance, Neoplasm1201953040.060 Why?
Adult1520242209690.060 Why?
Genetic Association Studies1201427340.060 Why?
Glioma1201934530.060 Why?
Hearing Disorders120241260.060 Why?
Stochastic Processes220153550.060 Why?
Combined Modality Therapy3202085160.060 Why?
Neoplasm Metastasis1201449100.050 Why?
Administration, Oral2202440100.050 Why?
Gene Expression Regulation, Developmental1201436080.050 Why?
Sensitivity and Specificity22015146480.050 Why?
Quinazolines2202013710.050 Why?
Time Factors22021399130.050 Why?
Aged, 80 and over72020588940.050 Why?
Hippocampus1201437610.050 Why?
Chemotherapy, Adjuvant2202035140.050 Why?
Ki-67 Antigen120236270.050 Why?
B-Lymphocytes1201447450.050 Why?
Epigenesis, Genetic1201437940.050 Why?
Immunologic Tests120211040.050 Why?
Pandemics1202186450.050 Why?
MicroRNAs1201738050.050 Why?
Premedication120212450.050 Why?
Gene Expression Regulation, Neoplastic1201785420.050 Why?
Risk Factors42022741150.040 Why?
Dexamethasone2201819470.040 Why?
Artificial Intelligence1201425740.040 Why?
Neoplasm Staging32021111160.040 Why?
Rifampin120213390.040 Why?
Models, Immunological120215120.040 Why?
Diagnostic Imaging1201335270.040 Why?
Bone Marrow2201929090.040 Why?
Neurilemmoma120245240.040 Why?
Sequence Analysis, RNA2201720140.040 Why?
Benzylamines120192460.040 Why?
Melanoma1201756970.040 Why?
Heterocyclic Compounds120192450.040 Why?
Tumor Burden1202418920.040 Why?
beta 2-Microglobulin120193280.040 Why?
Prostatic Neoplasms12021111060.040 Why?
Dioxygenases120203440.040 Why?
Follow-Up Studies42020390630.040 Why?
Tumor Suppressor Protein p532202029170.040 Why?
Creatinine1202318960.040 Why?
Cell Differentiation12014115140.040 Why?
Standard of Care120215510.040 Why?
Young Adult52024591790.030 Why?
Immunocompromised Host120218580.030 Why?
Cardiovascular Diseases12022154980.030 Why?
Administration, Cutaneous120187120.030 Why?
Purines120196060.030 Why?
Antigens, Neoplasm1202319850.030 Why?
Gene Dosage1202012170.030 Why?
Comparative Effectiveness Research120217080.030 Why?
Heterozygote1202227800.030 Why?
Hematologic Diseases120194960.030 Why?
Genome-Wide Association Study12015126610.030 Why?
Melphalan120174200.030 Why?
Aminopyridines120195730.030 Why?
Infusions, Intravenous1202022140.030 Why?
Karyotyping1201711710.030 Why?
Mass Spectrometry1202221890.030 Why?
Myeloid Differentiation Factor 88120195840.030 Why?
Retrospective Studies52023805660.030 Why?
Cisplatin1202016500.030 Why?
Databases as Topic120164730.030 Why?
Risk Assessment32021239720.030 Why?
Germ-Line Mutation1202218520.030 Why?
Comparative Genomic Hybridization120154730.030 Why?
Infection Control120219820.030 Why?
Immune System120197910.030 Why?
Immunologic Factors1202215890.030 Why?
Papillomaviridae1201911170.030 Why?
Cohort Studies32022414570.030 Why?
Mice, Inbred NOD1201718270.030 Why?
Exosomes120174240.030 Why?
Mice, SCID1201726250.020 Why?
Neoplastic Stem Cells1201913500.020 Why?
Gastrointestinal Diseases1201912010.020 Why?
Breast1202019630.020 Why?
Mice, Knockout22017143890.020 Why?
Predictive Value of Tests22019152510.020 Why?
Clinical Protocols1201514370.020 Why?
Reverse Transcriptase Polymerase Chain Reaction1201745700.020 Why?
PTEN Phosphohydrolase1201511130.020 Why?
Indoles1201718300.020 Why?
Isocitrate Dehydrogenase120159370.020 Why?
Xenograft Model Antitumor Assays1201735990.020 Why?
Mice42017813680.020 Why?
Air Pollution1202223550.020 Why?
Air Pollutants1202228930.020 Why?
Protein Kinase Inhibitors1202456720.020 Why?
Proto-Oncogene Proteins1202045120.020 Why?
Dose-Response Relationship, Drug12019107540.020 Why?
Sulfonamides1201719770.020 Why?
Models, Theoretical1201935670.020 Why?
Health Personnel1202133330.020 Why?
Radiology1202121130.020 Why?
Tumor Microenvironment1201938680.020 Why?
Gene Expression1201975680.020 Why?
Feasibility Studies1201752390.020 Why?
Boston1201993130.020 Why?
Homeodomain Proteins1201424130.020 Why?
Biopsy1201767620.020 Why?
Prevalence12022156890.020 Why?
Evidence-Based Medicine1201636800.010 Why?
Phenotype12022165710.010 Why?
Medicare1202267650.010 Why?
Animals420171682010.010 Why?
Apoptosis1201994760.010 Why?
DNA-Binding Proteins1202095860.010 Why?
Quality of Life12024133470.010 Why?
Child22024800790.010 Why?
Hospitalization12022107040.010 Why?
Adolescent22024882340.010 Why?
United States22022722720.010 Why?
Cell Line, Tumor12017169670.010 Why?
Case-Control Studies12017221480.010 Why?
Image Processing, Computer-Assisted1201489980.010 Why?
Magnetic Resonance Imaging12024364020.010 Why?
Signal Transduction12017234160.010 Why?
Infant12015361520.010 Why?
Child, Preschool12015421880.010 Why?
Trippa's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (272)
Explore
_
Co-Authors (152)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.